Two adults in their 60s were diagnosed with Guillain-Barre syndrome after getting the shot in a clinical trial.
Two people who took part in a clinical study and received Pfizer’s respiratory syncytial virus vaccine were subsequently diagnosed with a rare neurological condition, according to a briefingreleased Friday. Two adults in their 60s were confirmed to have Guillain-Barre syndrome after receiving the vaccine as part of Pfizer’s Phase 3 clinical trial for the shot, which has not yet been approved. Nearly 20,000 people got the shot for the trial.
The Food and Drug Administration has flagged the two cases as a cause for concern and called on Pfizer to conduct a safety study if the vaccine is approved. “Given the temporal association and biological plausibility, FDA agrees with the assessments of the investigators that these events were possibly related to study vaccine. … Therefore, [Guillain-Barre] is being considered an important potential risk,” the FDA said.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adultsThe FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential approval, which the company said it would do.
続きを読む »
Lizzo Embodies ’60s Glamour in a Coral Tweed SetLizzo Embodies '60s Glamor in a Coral Tweed Set
続きを読む »
Stacks (STX) up 30% Following this Major Release: Details.Stacks unveils two major releases to grow its Bitcoin as a DeFi hub vision
続きを読む »
2 women killed in separate shootouts in this Pa. city: reportTwo women were killed in two separate shootouts that occurred in Philadelphia early Thursday morning.
続きを読む »
Georgia linebacker Jamon Dumas-Johnson arrested on two driving chargesGeorgia linebacker Jamon Dumas-Johnson was booked for racing on highways/streets and reckless driving after a warrant was issued for his arrest.
続きを読む »